# Cultured Autologous Oral Mucosa Epithelial Sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency

> **NCT03949881** · PHASE1,PHASE2 · RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 40 (estimated)

## Conditions studied

- Total Bilateral Limbal Cell Deficiency

## Interventions

- **BIOLOGICAL:** FEMJA transplatation

## Key facts

- **NCT ID:** NCT03949881
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-11-13
- **Primary completion:** 2031-05-13
- **Final completion:** 2031-05-13
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03949881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03949881, "Cultured Autologous Oral Mucosa Epithelial Sheet for the Treatment of Bilateral Limbal Stem Cell Deficiency". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT03949881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*